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Supplemental Data
B 6 C lo n e 1 C lo n e 2 C lo n e 3 C lo n e 4 C lo n e 5 kB External Long Arm (C) Assessment of initial colony formation (left) and serial replating capacity (right) of 100 purified lineage-negative Sca1+ cKit+ (LSK) cells from 6-week-old primary Mx1-cre Srsf2 WT ("C1"), Mx1-cre Srsf2fl/fl ("KO"), Cre-negative Srsf2P95H ("C2"), and Mx1-cre Srsf2P95H ("KI") mice 2 weeks following pIpC injection. Error bars represent mean ± SD; *p < 0.05; **p < 0.001. Each graph displays data from a single biological replicate of the cell population sequenced. Figure 6K ).
A B C
14 Tables S1-S5 (Please see separately uploaded Excel files for Tables S1-S5) isoform for cassette exons ("se"), intron-proximal isoform for competing 3' or 5' splice site events ("a3ss", "a5ss"), inclusion of upstream exon for mutually exclusive exons ("mxe"), spliced isoform for intron retention events annotated as alternative ("ri") or constitutive ("ci"), and canonical splicing of constitutive junctions ("cj"). The table columns are defined as: "coords", genomic coordinates of splicing events; "gene", Ensembl gene ID; "geneName", name of gene;
"geneDescription", description of gene obtained from Ensembl; "type", class of splicing event;
"nmdTarget", whether isoform 1 of the event is a predicted NMD substrate (NA indicates that neither or all isoforms of the event are predicted NMD substrates); "deltaPsi_XX", difference in isoform ratio between the samples indicated by "XX". As Table S2 , but for MP cells. The distal LoxP cassette was inserted 87 bp upstream of exon 1. The point mutation, which alters a two-nucleotide sequence from CG to AC, was engineered in exon 1 of the mini-gene.
The mutation modifies the codon sequence to change the amino acid from Proline to Histidine.
The cassette LoxP-FRT-Neo-FRT was inserted immediately upstream of the mini-gene insertion site in intron 2-3. A second copy of exon 3 was fused to the end of exon 2 to enable an appropriate expression of the WT (wt) Srsf2 gene. The mutation CCG > CAC (resulting in an change of amino acid Proline 95 to Histidine) within exon 1 of the mini-gene was generated by 3-step PCR mutagenesis. 4 mutagenesis primers (Ex1KpnFw1, PT2, PT3 and Ex2EcoRIrev2)
were designed to amplify a fragment with the size of ~1.34 kb, which incorporates the mutation at the desired position. The PCR fragment carrying the point mutation was then inserted right after the cassette SV40pA-FRT-Neo-FRTLoxP in a shuttle vector. Then, the whole sequence including Neo cassette and the mini-gene was inserted in the location of the targeting vector as described above using the engineered enzyme site, BsiWI. color were mated to C57BL/6 FLP mice (The Jackson Laboratory) to remove the Neo cassette, and subsequently to IFNα-inducible Mx1-cre transgenic mice (Kuhn et al., 1995) . Mice were backcrossed for six generations to C57BL/6 mice (also previously described; (Mead et al., 2013; Moran-Crusio et al., 2011) ). Polyinosine-polycytosine (pIpC) (GE Healthcare (catalog # 27-4732-01)) was administered to 6-week-old mice at 12µg/g intraperitoneally every other day for 3 doses (as previously described (Mead et al., 2013; Moran-Crusio et al., 2011) ). Cell cycle and apoptosis analyses. For cell cycle analysis, the BrdU-APC kit was used (BD) according to the manufacturer's protocol. Mice were treated with 1 mg BrdU via intraperitoneal injection, followed by harvest of BM cells 24 h later. For evaluation of apoptosis, the Annexin V-FITC apoptosis detection kit (BD) was used according to manufacturer's recommendations.
Genotyping of
DAPI was used in both BrdU and Annexin V experiments.
Histological analysis. Mice were sacrificed and autopsied, and the dissected tissue samples were fixed for 24 h in 4% paraformaldehyde, dehydrated, and embedded in paraffin. Paraffin blocks were sectioned at 4 mm and stained with H&E. Images were acquired using an Axio Observer A1 microscope (Carl Zeiss).
Peripheral blood analysis. Blood was collected by retro-orbital bleeding using heparinized microhematocrit capillary tubes (Thermo Fisher Scientific). Automated peripheral blood counts were obtained using a HemaVet 950 (Drew Scientific) according to standard manufacturer's 21 instruction. Differential blood counts were realized on blood smears stained using WrightGiemsa staining and visualized using an Axio Observer A1 microscope.
Vector construction, viral infection, and cell culture (K562 cells). The SRSF2 cDNA sequence (NCBI identifier NM_003016) was used to generate the construct SRSF2 + Gly + Gly + FLAG + T2A + mCherry, where T2A is the cleavage sequence EGRGSLLTCGDVEENPGP. Gene ontology enrichment analysis. We used the GOseq method to perform gene ontology enrichment analysis, and performed a bias correction corresponding to the total number of RNA-seq reads mapping to each gene. This corrects for biases arising from both gene length and expression level as described in GOseq.
Cluster analysis. Cluster analysis was performed with a modified version of heatmap.2 in the R gplots package. All coding genes with expression >= 1 TPM (transcripts per million) in at least one sample were used to compute the Euclidean distance between samples. Following a zscore normalization, Ward's method was used to cluster the samples. 
NMR measurements and resonance assignments.
All measurements were conducted in the same buffer (50 mM arginine, 50 mM glutamine, 20 mM Na 2 HPO 4 /NaH 2 PO 4 , pH = 5.5) at a temperature of 37°C. We recorded our data on Bruker spectrometers ranging from 500 Mhz to 900 Mhz field strength, all equipped with cryo-probes.
The backbone assignment of the SRSF2 P95H mutant was facilitated by the previously published assignment of the wild type (Daubner et al., 2012 All samples including the template controls were assayed in triplicate. The relative number of target transcripts was normalized to the number of human 18s rRNA transcripts found in the same sample. The relative quantification of target gene expression was performed with the standard curve or comparative cycle threshold (CT) method.
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Semiquantitative RT-PCR. Total RNA was isolated using RNease Mini kit (Qiagen). For cDNA synthesis, total RNA was reverse transcribed with Verso cDNA kit (Thermo scientific). Human EZH2 exon 9-10 region was amplified using the forward 5ʹ′-TTTCATGCAACACCCAACACT -3ʹ′
and reverse 5ʹ′-CCCTGCTTCCCTATCACTGT -3' primer. The PCR cycling conditions (28 cycles) chosen were as follows: (1) 45s at 95 °C (2) 45s at 52 °C (3) 45s at 72 °C with a subsequent 5 min extension at 72 °C. Reaction products were analyzed on 2 % agarose gels.
The bands were visualized by ethidium bromide staining.
mRNA stability assay. For mRNA half-life measurement using qRT-PCR, UPF1 shRNA and shControl lentivirus infected K052 cells were treated with 2.5 µg/ml Actinomycin D and harvested at the indicated time points. EZH2 inclusion, EZH2 exclusion, SRSF3 inclusion and 18s rRNA mRNA levels were measured by RT-PCR as described above.
EZH2
minigene. An insert containing the EZH2 genomic locus (chr7:148515109-148516788) was cloned into the EcoRV site of pUB6/V5-HisA vector (Invitrogen) by Gibson assembly cloning (NEB). Site-directed mutagenesis was used to introduce C>G mutations at each SSNG motif within the cassette exon. Plasmids containing minigenes were transfected using the Nucleofector II device from Lonza with the Cell Line Nucleofector Kit V (program T16). RNA was collected after 48h. We isolated total RNA from K562 cells using TRIzol and extracted RNA using the Qiagen RNeasy kit. Complementary DNA (cDNA) was generated using 1 ug of total RNA with a primer specific to the minigene transcript immediately upstream of the poly(A) tail (ACAACAGATGGCTGGCAACTAGAAG). Assays were performed in biological triplicate.
Triplicates of equal amounts of 6 ng cDNA were used in a 5 uL reaction with 2.5 uL 2x SYBR Green PCR Master Mix (Life Technologies), and 50 nM forward and reverse primers. EZH2 primers: inclusion (forward CAGCATTTGCCACTCCTACC, reverse
